MA23586A1 - Traitement des besoins en nicotine et/ou du syndrome de manque lie au tabagisme - Google Patents

Traitement des besoins en nicotine et/ou du syndrome de manque lie au tabagisme

Info

Publication number
MA23586A1
MA23586A1 MA23929A MA23929A MA23586A1 MA 23586 A1 MA23586 A1 MA 23586A1 MA 23929 A MA23929 A MA 23929A MA 23929 A MA23929 A MA 23929A MA 23586 A1 MA23586 A1 MA 23586A1
Authority
MA
Morocco
Prior art keywords
nicotine
smoking
needs
treatment
related syndrome
Prior art date
Application number
MA23929A
Other languages
English (en)
Inventor
Majeti Satyanarayama
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MA23586A1 publication Critical patent/MA23586A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
MA23929A 1994-06-23 1995-06-16 Traitement des besoins en nicotine et/ou du syndrome de manque lie au tabagisme MA23586A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26466694A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
MA23586A1 true MA23586A1 (fr) 1995-12-31

Family

ID=23007084

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23929A MA23586A1 (fr) 1994-06-23 1995-06-16 Traitement des besoins en nicotine et/ou du syndrome de manque lie au tabagisme

Country Status (6)

Country Link
AU (1) AU2702795A (fr)
IL (1) IL114130A0 (fr)
MA (1) MA23586A1 (fr)
PE (1) PE39996A1 (fr)
WO (1) WO1996000069A1 (fr)
ZA (1) ZA955033B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034605A1 (fr) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Utilisation de nicotine pour traiter une hepatopathie
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
CA2325106A1 (fr) * 1999-12-06 2001-06-06 Stanley L. Gore Compositions et methodes permettant de liberer des agents actifs dans le cerveau
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4959380A (en) * 1988-12-19 1990-09-25 Wilson Jordan E Method of treating people to stop smoking and composition
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency

Also Published As

Publication number Publication date
WO1996000069A1 (fr) 1996-01-04
AU2702795A (en) 1996-01-19
ZA955033B (en) 1996-02-15
PE39996A1 (es) 1996-10-03
IL114130A0 (en) 1995-10-31

Similar Documents

Publication Publication Date Title
MA23587A1 (fr) Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
FR2726191B1 (fr) Dispositif de traitement du syndrome d'apnee pendant le sommeil
DE69619433T2 (de) Tabakrauchfilter und Verfahren zur Herstellung derselben
NO996314L (no) Fremgangsmåte for behandling av tobakk for å redusere innholdet av nitrosamin og produkter fremstilt av denne
DE69524365T2 (de) Verfahren zur Isolierung und Reinigung von 2'-Deoxy-2',2'-difluornucleosiden
DE69509544T2 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE69003977T2 (de) Verfahren und Einrichtung zur Bestimmung des Stengelgehaltes von Tabak.
DE69501493D1 (de) Entfernung von Feuchtigkeit und Passivierung von Oberflächen
NO951175D0 (no) Sigarettfilter og fremgangsmåte for dets fremstilling
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
MA23588A1 (fr) Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
MA23586A1 (fr) Traitement des besoins en nicotine et/ou du syndrome de manque lie au tabagisme
DE69306328D1 (de) Einrichtung zum automatischen Rauchen von Tabakrollen und zum Analysieren des Rauches
FR2751541B1 (fr) Composition dermo-cosmetique contenant un alcaloide du quinquina et methode de traitement cosmetique de l'alopecie
DZ3225A1 (fr) Methode et compositions pour le traitement des maladies pulmonaires
NO982562D0 (no) Sammensetning for behandling av smerte
ITMI931359A0 (it) Procedimento e dispositivo per l'essiccamento di tabacco
FR2751544B1 (fr) Composition therapeutique pour le traitement des verrues vulgaires
DE69503929T2 (de) Behandlung von Gasmischungen
BR9507375A (pt) Tratamento de superficies particuladas
MD654F1 (ro) Procedeu de prelucrare a tutunului Process of tobacco treatment
FR2718027B1 (fr) Produit destiné au traitement et à la prévention des alopécies.
FR2748907B3 (fr) Utilisation des galles et derives galliques dans la fabrication des cigarettes et le traitement des tabacs